Foxp3+ regulatory T cells: Differentiation, specification, subphenotypes

Nature Immunology

Volumn 10, Issue 7, 2009, Pages 689-695

  Feuerer, Markus ^a   Hill, Jonathan A ^a   Mathis, Diane ^a   Benoist, Christophe ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SPECIFICITY; ENZYME ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HOMEOSTASIS; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; THYMUS; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HUMANS; MODELS, IMMUNOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 67649170980     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1760     Document Type: Review

References (112)

1. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27 (2006).
2. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008).
3. Belkaid, Y. & Tarbell, K. Regulatory T cells in the control of host-microorganism interactions. Annu. Rev. Immunol. 27, 551-589 (2009).
4. Yamaguchi, T. & Sakaguchi, S. Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 16, 115-123 (2006).
5. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
6. Saoudi, A., Seddon, B., Heath, V., Fowell, D. & Mason, D. The physiological role of regulatory T cells in the prevention of autoimmunity: The function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149, 195-216 (1996).
7. Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73 (2001).
8. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
9. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
10. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
11. Ziegler, S.F. FOXP3: Of mice and men. Annu. Rev. Immunol. 24 209-226 (2006).
12. Hsieh, C.S., Zheng, Y., Liang, Y., Fontenot, J.D. & Rudensky, A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7, 401-410 (2006).
13. + T cells. Immunity 25, 249-259 (2006).
14. + T cells. J. Immunol. 178, 7032-7041 (2007).
15. Vignali, D.A., Collison, L.W. & Workman, C.J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532 (2008).
16. Fontenot, J.D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
17. + regulatory T cells. J. Exp. Med. 199, 303-313 (2004).
18. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199, 1479-1489 (2004).
19. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18, 1197-1209 (2006).
20. Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359-368 (2007).
21. Hill, J. et al. Foxp3-dependent and independent regulation of the Treg transcriptional signature. Immunity 25, 693-695 (2007).
22. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940 (2007).
23. Marson, A. et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931-935 (2007).
24. + regulatory T-cells in type 1 diabetes. Diabetes 56, 604-612 (2007).
25. + regulatory T lymphocytes. Eur. J. Immunol. 35, 3525-3532 (2005).
26. + regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 104, 18181-18186 (2007).
27. + T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 105, 11903-11908 (2008).
28. + T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J. Immunol. 175, 246-253 (2005).
29. + regulatory T cells participate in the control of immune responses. J. Immunol. 178, 6901-6911 (2007).
30. + T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115 2904-2913 (2005).
31. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440 (2000).
32. Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6 152-162 (2005).
33. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 283-284 (2001).
34. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
35. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168, 4399-4405 (2002).
36. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
37. Van Santen, H.M., Benoist, C. & Mathis, D. Number of Treg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200, 1221-1230 (2004).
38. Liston, A., Lesage, S., Wilson, J., Peltonen, L. & Goodnow, C.C. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4, 350-354 (2003).
39. Bonasio, R. et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7, 1092-1100 (2006).
40. + T cell receptors. Immunity 21, 267-277 (2004).
41. + regulatory T cells. Immunity 27, 493-504 (2007).
42. + T-cell development in a mouse expressing a transgenic TCR derived from a Treg. Eur. J. Immunol. 39, 234-240 (2009).
43. Bautista, J.L. et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10, 610-617 (2009).
44. Huesmann, M., Scott, B., Kisielow, P. & von Boehmer, H. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66, 533-540 (1991).
45. Merkenschlager, M., Benoist, C. & Mathis, D. Evidence for a single-niche model of positive selection. Proc. Natl. Acad. Sci. USA 91, 11694-11698 (1994).
46. Lio, C.W. & Hsieh, C.S. A two-step process for thymic regulatory T cell development. Immunity 28, 100-111 (2008).
47. Burchill, M.A. et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28, 112-121 (2008).
48. Li, M.O., Sanjabi, S. & Flavell, R.A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455-471 (2006).
49. + regulatory T cells. J. Exp. Med. 201, 1061-1067 (2005).
50. Pesu, M. et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455, 246-250 (2008).
51. + regulatory T cells. Nat. Immunol. 9, 632-640 (2008).
52. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl. Acad. Sci. USA 101, 4566-4571 (2004).
53. Gupta, S. et al. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol. Immunol. 46, 213-224 (2008).
54. Barnes, M.J. et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7, e51 (2009).
55. + regulatory T cells. J. Immunol. 182, 6736-6743 (2009).
56. Medoff, B.D. et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 39, 78-84 (2009).
57. Schmidt-Supprian, M. et al. Mature T cells depend on signaling through the IKK complex. Immunity 19, 377-389 (2003).
58. Sato, S. et al. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int. Immunol. 18, 1405-1411 (2006).
59. Wan, Y.Y., Chi, H., Xie, M., Schneider, M.D. & Flavell, R.A. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7, 851-858 (2006).
60. + cells. J. Exp. Med. 205 565-574 (2008).
61. Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105, 7797-7802 (2008).
62. Zheng, X.X. et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19, 503-514 (2003).
63. + regulatory T cells. Blood 105, 4743-4748 (2005).
64. + regulatory T cells cultured with rapamycin. J. Immunol. 178, 320-329 (2007).
65. + T cells in mice. Transpl. Immunol. 17, 153-161 (2007).
66. Delgoffe, G.M. mTor diferentially regulates effector and regulatory T cell lineage commitment. Immunity (in the press).
67. Huehn, J., Polansky, J.K. & Hamann, A. Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9, 83-89 (2009).
68. Hori, S. Rethinking the molecular definition of regulatory T cells. Eur. J. Immunol. 38, 928-930 (2008).
69. Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007).
70. Bacchetta, R. et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713-1722 (2006).
71. Haribhai, D. et al. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 182 3461-3468 (2009).
72. Allan, S.E., Song-Zhao, G.X., Abraham, T., McMurchy, A.N. & Levings, M.K. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol. 38, 3282-3289 (2008).
73. + T regulatory cells. J. Immunol. 178, 4022-4026 (2007).
74. Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).
75. Yu, A., Zhu, L., Altman, N.H. & Malek, T.R. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30, 204-217 (2009).
76. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
77. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
78. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 (2005).
79. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
80. Verginis, P., McLaughlin, K.A., Wucherpfennig, K.W., von, B.H. & Apostolou, I. Induction of antigen-specific regulatory T cells in wild-type mice: Visualization and targets of suppression. Proc. Natl. Acad. Sci. USA 105, 3479-3484 (2008).
81. Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933 (2005).
82. Sun, C.M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
83. + regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29, 114-126 (2008).
84. Knoechel, B., Lohr, J., Kahn, E., Bluestone, J.A. & Abbas, A.K. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202, 1375-1386 (2005).
85. + regulatory T cells by peripheral expansion. J. Immunol. 173, 7259-7268 (2004).
86. Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
87. + regulatory T cells in the steady state. J. Exp. Med. 198, 737-746 (2003).
88. Lathrop, S.K., Santacruz, N.A., Pham, D., Luo, J. & Hsieh, C.S. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205, 3105-3117 (2008).
89. Wong, J., Mathis, D. & Benoist, C. TCR-based lineage tracing: No evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. 204, 2039-2045 (2007).
90. Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431 (2007).
91. + Treg and control of Leishmania major infection. J. Immunol. 174, 5444-5455 (2005).
92. + Treg cells by infective larvae determines the outcome of filarial infection. Eur. J. Immunol. 39, 192-206 (2009).
93. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 179-189 (2006).
94. H17 and regulatory T cells. Nature 441, 235-238 (2006).
95. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 (2007).
96. Yang, X.O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56 (2008).
97. H17 cell differentiation by antagonizing RORγt function. Nature 453, 236-240 (2008).
98. Tsuji, M. et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323 1488-1492 (2009).
99. + T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106, 1903-1908 (2009).
100. Beriou, G. et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113, 4240-4249 (2009).
101. - regulatory T cells. Proc. Natl. Acad. Sci. USA 99, 13031-13036 (2002).
102. + regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204, 1335-1347 (2007).
103. + regulatory T cells originate from both naive T cells and naturally occurring naive-like regulatory T cells. J. Immunol. 180, 146-155 (2008).
104. Beyersdorf, N., Ding, X., Tietze, J.K. & Hanke, T. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. Eur. J. Immunol. 37, 3445-3454 (2007).
105. Siegmund, K. et al. Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106, 3097-3104 (2005).
106. Dudda, J.C., Perdue, N., Bachtanian, E. & Campbell, D.J. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559-1565 (2008).
107. H2 responses. Nature 458 351-356 (2009).
108. Koch, M.A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602 (2009).
109. Glimcher, L.H. Trawling for treasure: Tales of T-bet. Nat. Immunol. 8, 448-450 (2007).
110. Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55-79 (2004).
111. + regulatory T cells. J. Exp. Med. 204, 735-745 (2007).
112. Peng, S.L., Szabo, S.J. & Glimcher, L.H. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99, 5545-5550 (2002).